MedTrace Logo

Optimization of the Core Number and Location for Targeted Prostate Biopsy

NCT04983706 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-07-30

No results posted yet for this study

Summary

This study aims to investigate the effect of core number and location optimization for targeted prostate biopsy on pathological accuracy.

Conditions

Interventions

PROCEDURE

MRI/Ultrasound Fusion Saturation Biopsy

MRI/Ultrasound fusion saturation biopsy: the core number and location are designed according to the lession condition.

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-05
Primary Completion
2021-11-30
Completion
2022-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04983706 on ClinicalTrials.gov